Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:08 PM
Ignite Modification Date:
2025-12-24 @ 2:08 PM
NCT ID:
NCT00456495
Eligibility Criteria:
Inclusion Criteria:
* Ability to provide written informed consent and comply with study assessments for the full duration of the study
* Age \> 21 years
* Tumors whose treatment with standard therapy would cause significant visual morbidity
* Diagnosis of biopsy proven malignant conjunctival neoplasia and are
* Recurrent disease
* Multi-focal disease
* Diffuse disease
Exclusion Criteria:
* Extension of tumor into eye or orbit.
* Regional spread or metastatic disease
* Pregnancy (positive pregnancy test) or lactation.
* Premenopausal women not using adequate contraception. The following are considered effective means of contraception: surgical sterilization or use of oral contraceptives, barrier contraception with either a condom or diaphragm in conjunction with spermicidal gel, an IUD, or contraceptive hormone implant or patch.
* Current infection or inflammation in either eye
* Any other condition that the investigator believes would pose a significant hazard to the subject if the investigational therapy were initiated
* Participation in another simultaneous medical investigation or trial
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
21 Years
Study:
NCT00456495
Study Brief:
Protocol Section:
NCT00456495